Class-Action Suit Alleges Medtronic’s Rosy Forecast For MiniMed780G Misled Investors

The lawsuit says that Medtronic continued to predict that the new insulin pump would be FDA-approved shortly, even as other regulatory issues and recalls in the diabetes division made that less likely.